BlackRock Science and Technology Term Trust (BSTZ) 株式分析

企業概要

BlackRock Science and Technology Term Trust is a closed-ended equity mutual fund managed by BlackRock Advisors, LLC, which operates by seeking investments in stocks of companies operating within the science and technology sectors across global public equity markets. The fund functions within the Financial Services sector and specifically the Asset Management industry, providing a structured investment vehicle for exposure to specific technological and scientific enterprises. The company's current market capitalization stands at $1.61 billion, while specific figures for annual revenue and employee count are not disclosed in the available financial data. This market capitalization of $1.61 billion indicates that the fund has established a significant asset base, positioning it as a substantial entity within the closed-end fund landscape, although the lack of disclosed revenue and employee metrics limits the ability to assess operational breadth through traditional headcount or top-line growth indicators.

財務健全性

The available financial statements do not disclose specific figures for revenue, net income, or EBITDA, meaning that the gap between these metrics cannot be analyzed to determine the specific cost structure for this particular term trust. Similarly, data regarding free cash flow is not available, which precludes an analysis of the fund's inherent financial flexibility derived from operational cash generation. All three margin metrics—gross margin, operating margin, and profit margin—are reported at 0.0%, a characteristic common for closed-end funds that report net asset value per share rather than traditional corporate income statements, indicating that these standard profitability ratios do not apply in the conventional sense. The balance sheet data for total cash and total debt are not provided, making it impossible to compare liquidity assets against liabilities or to determine if the fund is conservative or leveraged. Furthermore, the current ratio is not disclosed, so the fund's short-term liquidity position relative to its current liabilities cannot be evaluated using standard solvency metrics. Finally, return on equity and return on assets are listed as unavailable, preventing an assessment of how effectively the fund's management utilizes shareholder capital or total assets to generate value.

バリュエーション評価

The trailing twelve-month P/E ratio is recorded at 5.04, whereas the forward P/E is not available, suggesting that forward-looking earnings expectations are either not projected or are not disclosed in the current reporting structure. The price-to-book ratio is not available, which limits the ability to determine if the fund is trading at a premium or discount relative to its underlying net asset value per share. Similarly, the price-to-sales ratio and EV/EBITDA metrics are unavailable, preventing an analysis of valuation relative to revenue generation or enterprise cash flows. The fund's stock price has traded between a 52-week high of $23.67 and a 52-week low of $16.01, establishing a clear historical trading range that investors can use to gauge current price positioning relative to recent volatility. The beta value is not available, so the fund's sensitivity to broader market movements relative to the overall market index cannot be quantified based on the provided data.

Growth & Income

Specific rates for revenue growth year-over-year and earnings growth year-over-year are not disclosed, so the trajectory of growth relative to revenue cannot be calculated or explained in this context. However, the fund does distribute income to shareholders, offering a dividend yield of 8.3%, which is a significant metric for income-seeking investors. The payout ratio is set at 51.7%, indicating that the fund distributes slightly more than half of its distributable earnings, a level that is generally considered sustainable for closed-end funds that rely on NAV appreciation and income distributions to support yields. The overall growth and income profile of BlackRock Science and Technology Term Trust is defined by its high dividend yield and the absence of standard growth metrics due to the nature of closed-end fund reporting, rather than traditional corporate expansion rates.